Oracle Health Drives Interoperability, Digital Check-In
AUSTIN, Texas, April 20, 2026 Oracle Health announced a major milestone in healthcare interoperability and digital transformation, achieving designation...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
AUSTIN, Texas, April 20, 2026 Oracle Health announced a major milestone in healthcare interoperability and digital transformation, achieving designation...
RARITAN, N.J., USA — April 1, 2026 Johnson & Johnson announced that its innovative bladder cancer therapy INLEXZO™ (gemcitabine...
February 25, 2026 – Nashville, Tennessee, USA OneOncology has announced that its Oncology Quality Hub has been officially approved...
SAN FRANCISCO, Calif., Oct. 7, 2025 — Verana Health announced the expansion of its MIPS Advisory Services, offering enhanced...
